Navigation Links
Advancements in Population Age and Technology Drive Future of Orthopedic Materials Market
Date:9/26/2007

NEW YORK, Sept. 26 /PRNewswire/ -- The world orthopedic biomaterials market, valued at $4 billion in 2006, is projected to accelerate in tandem with the world's aging population, reaching $8.8 billion in 2012, according to Orthopedic Biomaterials: World Market, a new report by Kalorama Information.

Changing demographics -- particularly a world population that is expected to include 2 billion individuals aged 60 or older by 2050, improved longevity, and higher quality-of-life expectations -- are driving the number of musculoskeletal conditions being diagnosed and treated across the globe. In Europe, 15-20% of all primary care consultations are for musculoskeletal conditions. In the United States, one out of every seven Americans reports a musculoskeletal impairment.

BMP (bone morphogenetic proteins) products, the newest and fastest growing segment in the orthopedic biomaterials market, are expected to increase their sales and holdings in the market during the forecasted period, growing by a CAGR of 25% to $2.9 billion and accounting for 39% of the market. Ceramic product sales, which accounted for 25% of the market in 2006, are projected to grow at a steady CAGR of 10% between 2006-2012 but account for only 21% of the orthopedic materials market by 2012.

"As a result of evolving technology, a number of biomaterials have been introduced to the market over the past several years, all of which are biologically active substances intended to extend, enhance, or even replace autologous graft," notes Anne Anscomb, the report's author. "However, it is the most recent innovations in the orthopedic biomaterials, the development of recombinant bone morphogenetic proteins (BMPs) and synthetic ceramic products, which show the greatest promise in the quest for the perfect orthopedic biomaterial."

Orthopedic Biomaterials: World Market focuses on products and markets for bone allografts and bone graft substitutes, which include allograft bone substitutes, ceramic-based, polymer-based, factor-based and hyaluronic acid synovial Fluid substitutes. The report analyzes products in development and on the market, leading competitors, and current issues and trends affecting the industry. This report can be purchased directly from Kalorama Information by visiting: http://www.kaloramainformation.com/Orthopedic-Biomaterials-Edition-1399489.

About Kalorama Information

Kalorama Information publishes the latest independent market research on medical markets, including biotechnology, pharmaceuticals, diagnostics, medical devices, and healthcare sectors. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.

Contact:

Tom Ehart

MarketResearch.com

240-747-3014

tehart@marketresearch.com


'/>"/>
SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Liability issues not seen as roadblock to healthcare technology advancements
2. Governor Doyle Pledges Support for Stem Cell Research and Biotechnology Advancements
3. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
4. Using the DCode System to Identify DNA Sequence Variation for Studies of Population Structure in Marine Organisms
5. Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays
6. Laser Capture Microdissection of muscle fiber populations and expression analysis by RT-PCR
7. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
8. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
9. Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep Technology
10. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
11. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Elekta is pleased to announce ... industry-leading treatment planning software, is available for clinical release. ... version 5.11 provides significant performance speed enhancements over ... to four times faster than in previous versions of ... standard Monte Carlo algorithm, users ...
(Date:4/28/2016)... ... April 28, 2016 , ... As part ... top industry experts, and expanding its LATAM network and logistics capabilities. Enhancements ... to manage their clinical trial projects. , The expansion will provide unmatched clinical ...
(Date:4/27/2016)... ... 27, 2016 , ... Most consumers engage with biometrics technology ... secure access, voice recognition for hands-free communication, and facial recognition to help organize ... technology today. But if they asked Joey Pritikin, Vice President of Marketing ...
(Date:4/27/2016)... MD (PRWEB) , ... April 27, 2016 , ... ... Greg Lamka, PhD to its Scientific Advisory Board. Dr. Lamka will assist PathSensors ... plant pathogen detection. , PathSensors deploys the CANARY® test platform for the ...
Breaking Biology Technology:
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
(Date:3/18/2016)... --> --> ... & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection ... border security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, ... defence & security companies in the border security ...
(Date:3/15/2016)... , March 15, 2016 Yissum ... , the technology-transfer company of the Hebrew University, announced ... of remote sensing technology of various human biological indicators. ... raising $2.0 million from private investors. ... based on the detection of electromagnetic emissions from sweat ...
Breaking Biology News(10 mins):